Muscle wasting: A nutritional criterion to prioritize patients for liver transplantation

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 3, 2014, Pages 219-225

  Montano Loza, Aldo J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

cirrhosis; liver transplant; organ allocation; sarcopenia; scores for prognosis

Indexed keywords

ASCITES; BODY COMPOSITION; COMPUTER ASSISTED TOMOGRAPHY; EXERCISE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; MUSCLE ATROPHY; MUSCLE METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROGNOSIS; PROTEIN INTAKE; REVIEW; SEPSIS; COMPLICATION; MUSCULAR ATROPHY; NUTRITIONAL STATUS; SEVERITY OF ILLNESS INDEX; WASTING SYNDROME;

BODY COMPOSITION; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MUSCULAR ATROPHY; NUTRITIONAL STATUS; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; WASTING SYNDROME;

EID: 84898539044     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000046     Document Type: Review

References (33)

1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371:838-851.
2. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 10:166-173.
3. Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013; 47:861-870.
4. Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013; 13:1549-1556.
5. Krell RW, Kaul DR, Martin AR, et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013; 19:1396-1402.
6. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211:271-278.
7. Johnson TM, Overgard EB, Cohen AE, DiBaise JK. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract 2013; 28:15-29.
8. O'Brien A, Williams R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008; 134:1729-1740.
9. Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle 2012; 3:225-237.
10. Lang PO, Michel JP, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009; 55:539-549.
11. Lang T, Streeper T, Cawthon P, et al. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 2010; 21:543-559.
12. Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab 2010; 35:707-712.
13. Montano-Loza AJ. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients. Minerva Gastroenterol Dietol 2013; 59:173- 186.
14. Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis 2011; 15:685-698.
15. Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis 2012; 16:95-131.
16. Hayashi F, Matsumoto Y, Momoki C, et al. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis. Hepatol Res 2013; 43:1264-1275.
17. Montano-Loza AJ, Meza-Junco J, Prado CMM, et al. Sarcopenic obesity and muscle fat infiltration are associated with higher mortality in patients with cirrhosis. Hepatology 2013; 58 (S1):865A.
18. Glass C, Hipskind P, Tsien C, et al. Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study. J Appl Physiol 2013; 114:559-565.
19. Heymsfield SB. Development of imaging methods to assess adiposity and metabolism. Int J Obes (Lond) 2008; 32 (Suppl 7):S76-S82.
20. Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33:997-1006.
21. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9:629-635.
22. Montano-Loza AJ, Meza-Junco J, Prado CMM, et al. New cutoff values for sarcopenia for predicting 6-months mortality in cirrhotic patients. J Hepatol 2013; 58 (S1):95A.
23. Vaisman N, Katzman H, Carmiel-Haggai M, et al. Breakfast improves cognitive function in cirrhotic patients with cognitive impairment. Am J Clin Nutr 2010; 92:137-140.
24. Kachaamy T, Bajaj JS. Diet and cognition in chronic liver disease. Curr Opin Gastroenterol 2011; 27:174-179.
25. Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis. Curr Opin Clin Nutr Metab Care 2008; 11:222-226.
26. Dreyer HC, Drummond MJ, Pennings B, et al. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Physiol Endocrinol Metab 2008; 294:E392-E400.
27. Tsien C, Shah SN, McCullough AJ, Dasarathy S. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur J Gastroenterol Hepatol 2013; 25:85-93.
28. Dasarathy J, Alkhouri N, Dasarathy S. Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature. Liver Int 2013; 31:1250-1258.
29. Garcia PS, Cabbabe A, Kambadur R, et al. Brief-reports: elevated myostatin levels in patients with liver disease - a potential contributor to skeletal muscle wasting. Anesth Analg 2010; 111:707-709.
30. Dasarathy S, McCullough AJ, Muc S, et al. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J Hepatol 2011; 54:915- 921.
31. Montano-Loza AJ, Meza-Junco J, Baracos VE, et al. Muscle wasting is not associated with higher mortality after liver transplantation. Hepatology 2012; 56 (S1):651A.
32. Dasarathy S. Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation. Dig Dis Sci 2013; 58:3103-3111.
33. Montano-Loza AJ, Meza-Junco J, Prado CMM, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Hepatology 2013; 58 (S1):1041A.